Antiproliferative and cytotoxic effects of single and combined treatment with tumor necrosis factor alpha and/or alpha interferon on a human renal cell carcinoma xenotransplanted into nu/nu mice: cell kinetic studies
- PMID: 2400997
Antiproliferative and cytotoxic effects of single and combined treatment with tumor necrosis factor alpha and/or alpha interferon on a human renal cell carcinoma xenotransplanted into nu/nu mice: cell kinetic studies
Abstract
A human renal cell carcinoma serially transplanted into nude mice was treated with recombinant human tumor necrosis factor alpha (TNF-alpha), recombinant human alpha interferon (IFN-alpha), and a combination of both. All treatments resulted in a significantly reduced tumor growth. The greatest effect was obtained with the combination of TNF-alpha and IFN-alpha. This latter treatment completely eradicated tumors which were smaller than 50 mm3 at the beginning of treatment. Cell kinetic analysis using the bromodeoxyuridine technique and flow cytometry revealed a prolongation of the transition time through S-phase from 7.9 h in the case of control tumors to 10.5 h for tumors treated with IFN-alpha and TNF-alpha. Single treatment with either TNF-alpha or IFN-alpha had only minor effects. The bromodeoxyuridine labeling index was unaffected by IFN-alpha (16.6%; control, 15.2%) but was reduced to 12.1 and 11.7% when tumors were treated with TNF-alpha and IFN-alpha plus TNF-alpha, respectively. The calculated potential doubling times were 2.3 and 2.8 days, respectively, for tumors treated with TNF-alpha or IFN-alpha plus TNF-alpha. When treated with IFN-alpha, the potential doubling time (1.7 days) was similar to that of the control (1.6 days), indicating that the main effect of TNF-alpha was antiproliferative. Conversely, the calculated cell loss factors increased after IFN-alpha and combined treatment but not after TNF-alpha treatment. Combined treatment augmented cytotoxicity, but the cell kinetic characteristics of surviving cells remained similar to those of tumors treated with TNF-alpha alone. Histological analysis showed a distinctly reduced mitotic activity but no coagulative necroses after treatment with TNF-alpha. IFN-alpha and, in particular, IFN-alpha plus TNF-alpha induced cytoplasmic vacuolization, nuclear pyknosis, and cell death, which resulted in tumor regression. These data suggest that, in this particular tumor model, TNF-alpha produces mainly antiproliferative effects, whereas IFN-alpha acts via cytotoxic mechanisms.
Similar articles
-
[In vivo anti-tumour efficacy of tumour necrosis factor and interferon- alpha, -gamma on human renal cell carcinoma heterotransplanted in nude mice].Nihon Gan Chiryo Gakkai Shi. 1990 Aug 20;25(8):1571-8. Nihon Gan Chiryo Gakkai Shi. 1990. PMID: 2121869 Japanese.
-
[Anti-neoplastic activity of a human recombinant tumor necrosis factor (Hu-rec-TNF) alone or in combination with human recombinant gamma-interferon, doxorubicin or cis-platinum on a human renal cell carcinoma line].Hinyokika Kiyo. 1987 Mar;33(3):329-35. Hinyokika Kiyo. 1987. PMID: 3113191 Japanese.
-
Myelopoiesis-associated immune suppressor cells in mice bearing metastatic Lewis lung carcinoma tumors: gamma interferon plus tumor necrosis factor alpha synergistically reduces immune suppressor and tumor growth-promoting activities of bone marrow cells and diminishes tumor recurrence and metastasis.Cancer Res. 1992 Nov 15;52(22):6335-40. Cancer Res. 1992. PMID: 1423279
-
[The value of interferons, interleukin-2 and tumor necrosis factor in the therapy of renal cell cancer].Urologe A. 1991 Mar;30(2):77-80. Urologe A. 1991. PMID: 1711729 Review. German.
-
Interferon-alpha and interleukin-2 in the treatment of renal cell cancer.Prog Clin Biol Res. 1990;348:61-9. Prog Clin Biol Res. 1990. PMID: 2201034 Review. No abstract available.
Cited by
-
Hypertension and Circulating Cytokines and Angiogenic Factors in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma Treated With Sunitinib: Results From a Phase II Trial.Oncologist. 2015 Oct;20(10):1140-8. doi: 10.1634/theoncologist.2015-0143. Epub 2015 Aug 25. Oncologist. 2015. PMID: 26306901 Free PMC article. Clinical Trial.
-
Chemo-adoptive immunotherapy of nude mice implanted with human colorectal carcinoma and melanoma cell lines.Cancer Immunol Immunother. 1992;35(2):135-44. doi: 10.1007/BF01741861. Cancer Immunol Immunother. 1992. PMID: 1596937 Free PMC article.
-
Isolated perfusion of the kidney with tumor necrosis factor for localized renal-cell carcinoma.World J Urol. 1996;14 Suppl 1:S2-7. doi: 10.1007/BF00182056. World J Urol. 1996. PMID: 8738402 Review.
-
Cytotoxic effect of diphtheria toxin used alone or in combination with other agents on human renal cell carcinoma cell lines.Urol Res. 1994;22(4):261-6. doi: 10.1007/BF00541904. Urol Res. 1994. PMID: 7871641
-
Differential sensitivity of hormone-responsive and unresponsive human prostate cancer cells (LNCaP) to tumor necrosis factor.Urol Res. 1992;20(3):193-7. doi: 10.1007/BF00299716. Urol Res. 1992. PMID: 1615580
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials